StemRIM Inc.

4599・Growth Market・Pharmaceuticals

Official website

StemRIM Inc.

4599・Growth Market・Pharmaceuticals

Official website

StemRIM Inc.4599

Reference Indicators

Market Cap

204¥100M

P/E (Forecast)

—

P/B

3.5x

Dividend Yield (Forecast)

0.00%

ROE

-32.9%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Jul 2022	2023Jul 2023	2024Jul 2024	2025Jul 2025
Net Sales	22	2,350	—	—
SG&A Expenses	582	640	622	576
Operating Income	-1,980	142	-2,076	-1,971
Non-operating Income	8	3	0	1
Non-operating Expenses	0	0	2	0
Ordinary Income	-1,972	145	-2,077	-1,970
Extraordinary Income	26	24	59	42
Extraordinary Losses	—	—	—	0
Pre-tax Income	-1,946	170	-2,018	-1,927
Income Taxes	2	1	3	1
Net Income	-1,948	168	-2,022	-1,929
EBITDA	-1,931	190	-2,031	-1,922
Operating Margin	-8620.7%	6.1%	—	—
ROA	-20.3%	1.6%	-22.3%	-25.7%
ROE	-22.9%	1.9%	-26.7%	-32.9%